Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1980-2026

Dimension Creatinine Flex reagent cartridge. Material Number: 10872079. Recall

Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1980-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 18, 2026
FDA report date
May 6, 2026
Quantity in commerce
18,080 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.

Affected model & UDI checker

Search the exact identifiers published for Z-1980-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
DF33B.Dimension Creatinine Flex reagent cartridge. Material Number: 10872079.Check source notice00630414595009
DF33BDimension Creatinine Flex reagent cartridge. Material Number: 10872079.Check source noticeNot specified
FDA code information

Material Number: 10872079. Model Number: DF33B. UDI: (01)00630414595009(10)GA6307(17)20261103, (01)00630414595009(10)BA7005(17)20270105. Lot Numbers: GA6307, BA7005.

View the original FDA recall notice

Why was this product recalled?

Siemens Healthcare Diagnostics is recalling certain lots of Dimension Creatinine Flex reagent cartridge (Dimension CRE2) because a potential imprecision in the Dimension CRE2 quality control (QC) and patient sample results using lot numbers GA6307 and BA7005 on the Dimension System. This imprecision may lead to erroneously decreased or increased creatinine patient results

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Siemens Healthcare Diagnostics, Inc. take?

Siemens Healthineers notified consignees on about 03/18/2026 via letter. Consignees were notified of the issue, the hazard involved and instructed to immediately discontinue use of and discard the affected kit lots, each facility should review the recall notification with their Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable, and review inventory to determine the laboratory's replacement needs and communicate that with Siemens Healthineers. Consignees were also instructed to complete and return the Field Correction Effectiveness Check Form provided and retain the letter with laboratory records and forward it to anyone how may have received or used the affected product.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology